genprowebdirectory
GEN Edge
News
Insights
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
GEN Edge
Regeneron Hits the Accelerator
GEN Edge
Global Blood Therapeutics CEO Defends Price of Sickle-Cell Drug Oxbryta
GEN Edge
Trial Triumphs, Takeover Talk Boost Reata Pharmaceuticals
GEN Edge
GenapSys Pursues Partnership with China CDC to Detect Coronavirus
Zinc Finger Nucleases
From Alzheimer’s to Zinc Fingers
News
base editing
CRISPR Base Editor Repairs Faulty Genes in Cystic Fibrosis Organoids
News
GSK, Immatics Ink Up-to-$1B Cancer Immunotherapy Collaboration
News
Macrolide Antibiotics Prescribed During Early Pregnancy Linked with Major Birth Defects
News
Novel Molecular Pathway Involved in the Immunotherapy Response Identified
Coronavirus
Coronavirus SARS-CoV-2 Spike Structure Mapped at Atomic Scale by Cryo-EM
Insights
All
Trends for 2020
Coronavirus
What We Know Today about Coronavirus SARS-CoV-2 and Where Do We…
Bioprocessing
Ruminating on Bioprocessing 4.0
Bioprocessing
Cell Out? Lysate-Based Expression an Option for Personalized Meds
Bioprocessing
Leap into Efficient Cell Lines
A-Lists
Insights
Top 10 Life Sciences Jobs Most in Demand over the Next…
GEN Edge
Ten Life Science Analysts to Watch in 2020
Insights
Top 10 Young Companies in the Money, 2019
January 2020 Vol. 40 No. 1
8 Biopharma Trends to Watch in 2020
Cancer
Top 10 Immuno-Oncology Startups of 2019
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
base editing
CRISPR Base Editor Repairs Faulty Genes in Cystic Fibrosis Organoids
News
GSK, Immatics Ink Up-to-$1B Cancer Immunotherapy Collaboration
News
Macrolide Antibiotics Prescribed During Early Pregnancy Linked with Major Birth Defects
News
Novel Molecular Pathway Involved in the Immunotherapy Response Identified
Magazine
February 2020 Vol. 40 No. 2
Building SynBio Platforms to Support Practical Apps
February 2020 Vol. 40 No. 2
Phage Therapy May Combine Efficacy and Convenience
February 2020 Vol. 40 No. 2
Guilty as Charged
February 2020 Vol. 40 No. 2
Gene Therapy Dollar Is Waiting on Viral Vector Dime
February 2020 Vol. 40 No. 2
Antibody Screening Technology Is Never Out of Sorts
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Upcoming Webinars
The Successful Evolution of Biotherapies from Discovery to Development
February 2020 Vol. 40 No. 2
A Small-Footprint, Integrated, and Automated Platform for Viral Production
Drug Discovery
Assessing Phenotypic Changes in Zebrafish through Automated Quantitative Imaging
10x Genomics
Bridging Genomics and Tissue Pathology
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Zinc Finger Nucleases
Zinc Finger Nucleases
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Zinc Finger Nucleases
From Alzheimer’s to Zinc Fingers
Zinc Finger Nucleases
Sangamo Researchers Show Improvements to Zinc Finger Nuclease Technology
Zinc Finger Nucleases
Sangamo Looks to Expand into CAR-Treg Cell Therapies with TxCell Acquisition
Zinc Finger Nucleases
Kite, Sangamo Launch Up-to-$3B+ Cancer Cell Therapy Partnership
Zinc Finger Nucleases
Sangamo, Pfizer Partner on Gene Therapy for ALS, FTLD
Zinc Finger Nucleases
Sangamo Genome Editing Trial, Assessing MPS II Candidate, Treats First Patient
Zinc Finger Nucleases
Genetically Engineered Pigs May Fly as Cancer Models
Zinc Finger Nucleases
A Tap of Radiation Enhances Gene Editing of Human Stem Cells
Zinc Finger Nucleases
Gene Editing Technique Boosts Patients’ HIV Resistance
Zinc Finger Nucleases
Genetic Bug Spray? Scientists Alter Mosquitoes’ Sense of Smell
Zinc Finger Nucleases
Sigma Divisions Establish Screening Technology Deals
Zinc Finger Nucleases
Turning on Genes with The Blues
Zinc Finger Nucleases
Synthetic Biology Expands Beyond Bacteria
Zinc Finger Nucleases
Naked ZFNs Point to More Efficient, Safer Gene Therapy
Zinc Finger Nucleases
Shire, Sangamo Ink $13M Up-Front Deal for ZFPs against Hemophilia and...
Load more
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
![Sangamo Therapeutics aims to position itself as a leader in the development of chimeric antigen receptor-modified regulatory T-cell (CAR-Treg) cell therapies for immunological diseases with its planned acquisition of TxCell. [Source: TxCell]](https://www.genengnews.com/wp-content/uploads/2018/08/ENTrIA_recognition_EN_without_entria1024x9291472362223-265x198.png "Sangamo Looks to Expand into CAR-Treg Cell Therapies with TxCell Acquisition")
